Collectively, we first reported a new molecular mechanism that NE-mediated activation of the AKT/β-catenin/SLUG axis promoted ovarian cancer metastasis induced by CRS, which partially suggested the necessity of psychological, behavioral, pharmacological intervention against negative emotions in patients with ovarian cancer. The gene discussed is AKT1; the disease is ovarian carcinoma.